Skip to search formSkip to main contentSkip to account menu

teferrol

Known as: IRON POLYMALTOSE, iron(III)-hydroxide-dextrin, iron hydroxide polymaltose 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

Ferric CompoundsHematinics

Narrower (2)

IntraferNoripurum

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Ефективність раннього застосування тривалентного заліза з метою профілактики анемії у недоношених новонароджених. Огляд міжнародного досвіду.
Studies have been performed to determine the efficacy of early application of trivalent ferrum in the form of iron(III)-hydroxide… 
Review
2015
Review
2015
Железодефицитная анемия во время беременности - профилактика и лечение
The review is devoted to the prevention and treatment of anemia during pregnancy. Iron deficiency anemia (IDA) is the most common… 
Review
2009
Review
2009
Iron polymaltose use in chronic kidney disease patients: one unit's experience
Background: A major concern of iron therapy is the safety and related adverse events, in particular, the association of iron… 
2008
2008
Florence Henri y la vanguardia europea en las Islas Baleares (1930-1936)
Durante el primer tercio del siglo XX, las Islas Baleares fueron uno de los destinos privilegiados para ciertos miembros de las… 
1992
1992
Hausmann und Abteilungsleiterin: die Auswirkungen von Geschlechtsrollenerwartungen und rollendiskrepantem Verhalten auf die Zuschreibung von Persönlichkeitseigenschaften: Househusband and career…
1991
1991
Kinetics of Fe(III)-hydroxide-polymaltose supplied orally, intravenously and intramuscularly to rats as obtained by radiotracer techniques
1987
1987
Intestinal absorption of 59Fe from neutron-activated commercial oral iron(III)-citrate and iron(III)-hydroxide-polymaltose complexes in man.
: Commercial oral iron preparations (drops) containing trivalent iron either as a citrate (C) or hydroxide-polymaltose complex… 
1987
1987
Intestinal absorption of 59Fe from neutron-activated commercial oral iron(III)-citrate and iron(III)-hydroxide-polymaltose complexes in man.
Commercial oral iron preparations (drops) containing trivalent iron either as a citrate (C) or hydroxide-polymaltose complex (HP… 
1987
1987
Equivalent bioavailability of iron from ferrous salts and a ferric polymaltose complex. Clinical and experimental studies.
In both experimental animals and human subjects iron absorption over a wide dosage range was quantitatively equivalent from… 
1979
1979
The bioavailability of an iron polymaltose complex for treatment of iron deficiency.